US Patent 7683054 Galenic formulations of organic compounds
Patent 7683054 was granted and assigned to Novartis on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+314 characters)
Article
Patent abstract
The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and wherein the active ingredient is present in an amount of more than 46% by weight based on the total weight of the oral dosage form.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Martin Schmid0
Petra Gisela Rigassi-Dietrich0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07683054 Galenic formulations of organic compounds US Patent 7683054 Galenic formulations of organic compounds
Infobox
Patent Number
076830540
Patent Number
76830540
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076830540
Date of Patent
March 23, 2010
0Patent Application Number
111192730
Date Filed
April 29, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07683054 Galenic formulations of organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07683054
Date of patent
March 23, 2010
Patent application number
11119273
Date Filed
April 29, 2005
Patent primary examiner
Find more entities like US Patent 7683054 Galenic formulations of organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
